Home » Business » AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal

By Fari Haue Monday, November 23, 2020 Business

AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal

Bagikan Berita Ini

0 Response to "AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal"

Post a Comment

Subscribe to: Post Comments (Atom)